AVEO Pharmaceuticals (AVEO) PT Raised to $12 at H.C. Wainwright After TIVO-3 OS Meets NDA Filing Threshold
Tweet Send to a Friend
H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on AVEO Pharmaceuticals (NASDAQ: AVEO) to $12.00 (from $10.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
